“I’m thrilled to join this world-class team and apply my cybersecurity, SaaS, and enterprise expertise to help advance the technology that has enabled thousands of global HDO’s to successfully manage and secure digital identities across healthcare’s hyper-complex environment.” – Mark McArdle, Senior Vice President of Products and Design, Imprivata
Biometric patient identification specialist Imprivata has a new head of product: Mark McArdle has been named the company’s Senior Vice President of Products and Design.
In announcing McArdle’s appointment, Imprivata highlighted his previous experience at cybersecurity firms eSentire and McAfee. He was eSentire’s CTO from 2014 to 2018, and also headed its CyberSecurity Managed Detection and Response team. At McAfee, he was SVP of Consumer Product Development from 1997 to 2008.
McArdle also has experience in other areas. From November of 2010 to March of 2011, he was CEO of mobile app tool developer tinyHippos, which was acquired by Research in Motion; and from April of 2012 to November of 2012 he was CEO of digital media firm Rebellion Media.
At Imprivata, McArdle’s will oversee product development across the company’s portfolio, in line with Imprivata’s “digital identity framework for healthcare” program.
“A passionate out-of-the-box thinker and innovator, Mark will be instrumental in leading our product strategy in alignment with our company vision, which includes both our current foundational and market-leading solutions, as well as our developing product lines for future market opportunities,” explained Imprivata CEO Gus Malezis.
For his part, McArdle called Imprivata “the world leader in trusted digital identity management for healthcare delivery organizations,” and expressed his enthusiasm for his new mission. “I’m thrilled to join this world-class team and apply my cybersecurity, SaaS, and enterprise expertise to help advance the technology that has enabled thousands of global HDO’s to successfully manage and secure digital identities across healthcare’s hyper-complex environment,” he said.
McArdle’s appointment comes about a month after Imprivata announced a partnership with Keyo to develop a contactless version of its PatientSecure palm vein identification solution.
November 12, 2020 – by Alex Perala